All lobbying filings

The Good Food Institute

The Good Food Institute filed a Q2 report for The Good Food Institute on July 20, 2026.

Lobbying for The Good Food Institute

As filed: THE GOOD FOOD INSTITUTE for THE GOOD FOOD INSTITUTE.

All filings by The Good Food Institute · Everything The Good Food Institute has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Expenses

$60,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Virginia

Official filing document

Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Food Industry (safety, labeling, etc.)

Funding for plant-based, cultivated, and fermentation-enabled proteins through the Agriculture and Food Research Initiative; FAIR Labels Act of 2026; FDA Review and Evaluation for Safe, Healthy, and Affordable Foods Act; federal legislative proposals related to reforming FDAs Generally Recognized As Safe (GRAS) program; issues impacting plant-based, cultivated, and fermentation-enabled foods in the 2026 Farm Bill; legislative proposals related to using innovative protein technology to support lactoferrin production.

Budget/Appropriations

Appropriations to support commercialization of the plant-based, cultivated, and fermentation-enabled industries through the National Defense Authorization Act and the Farm Bill; FY27 appropriations to build out a federal biotech data repository.

Science/Technology

The House BIOTech Caucus and driving bio-innovation through innovative proteins; federal biotech policies related to cultivated, plant-based, and fermentation-enabled protein technologies, including allocating funding through the Distributed Bioindustrial Manufacturing Program and the Biobased Manufacturing Assistance Program; establishment of a federal biotech data repository.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.